Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Other Accumulated Expenses (2017 - 2018)

Cue Biopharma's Other Accumulated Expenses history spans 2 years, with the latest figure at $79188.0 for Q4 2018.

  • For Q4 2018, Other Accumulated Expenses fell 19.08% year-over-year to $79188.0; the TTM value through Dec 2018 reached $79188.0, down 19.08%, while the annual FY2018 figure was $79188.0, 19.08% down from the prior year.
  • Other Accumulated Expenses for Q4 2018 was $79188.0 at Cue Biopharma, down from $97857.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $97857.0 in Q4 2017 and bottomed at $79188.0 in Q4 2018.